Author | Charles J. Ryan, MD | OncLive

Author | Charles J. Ryan, MD

Articles

Dr. Ryan on Bone-Targeting Agents for Patients With Prostate Cancer

November 01, 2017

Video

Charles J. Ryan, MD, professor of medicine and urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, discusses bone-targeting agents for patients with prostate cancer.

Dr. Charles Ryan Discusses IMAAGEN Trial Update for Prostate Cancer

June 23, 2016

Video

Charles J. Ryan, MD, professor of Clinical Medicine, Urology, Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, provides an update to the IMAAGEN trial, which explored the effects of abiraterone acetate (Zytiga) and low-dose prednisone on prostate-specific antigen and radiographic disease progression in patients with nonmetastatic castration-resistant prostate cancer

Dr. Charles Ryan on Abiraterone in mCRPC

March 09, 2015

Video

Charles J. Ryan, MD, Professor of Clinical Medicine, Urology, Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), discusses the effects he has seen abiraterone have in patients with metastatic castration-resistant prostate cancer (mCRPC).

x